Baillie Gifford & Co’s Doximity DOCS Stock Holding History
Bought
Maintained
Sold
Other funds holding DOCS
Baillie Gifford & Co's DOCS Position: Q2 2026 in Review
Baillie Gifford & Co reduced its Doximity (DOCS) stake by 83% in Q2 2026, selling an estimated $70.7M and leaving 643,675 shares worth $13.3M. The position accounts for 0.01% of the portfolio, ranked #193.
Baillie Gifford & Co first reported a position in DOCS in Q3 2022 and has held it in 16 quarters since. The position peaked at $282M in Q3 2025. 358 funds tracked by Wall St. Rank hold DOCS as of Q2 2026.
- Baillie Gifford & Co held 643,675 shares of Doximity worth $13.3M as of Q2 2026.
- Baillie Gifford & Co sold 3,195,952 Doximity shares in Q2 2026, an estimated $70.7M.
- Doximity made up 0.01% of Baillie Gifford & Co's portfolio in Q2 2026, its #193 holding.
- Baillie Gifford & Co first reported a position in Doximity in Q3 2022 and has held it in 16 quarters since.
- Baillie Gifford & Co's Doximity position peaked at $282M in Q3 2025.
- 358 funds tracked by Wall St. Rank held Doximity as of Q2 2026.
Based on Baillie Gifford & Co's 13F filing for Q2 2026, filed 6 Aug 2026.